OCC 1.32% 38.5¢ orthocell limited

BioHorizons may have only 10% of the implant market worldwide...

  1. 144 Posts.
    lightbulb Created with Sketch. 18
    BioHorizons may have only 10% of the implant market worldwide but with this deal they are not looking to only market to their existing customers.

    OCC have a unique product that none of BioHorizons' competitors are able to provide. So BioHorizons will be using Striate to break into their competitor's market.

    DYOR


 
watchlist Created with Sketch. Add OCC (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.